New Products and Industry News

Login toDownload PDF version

Autologous blood clot product FDA cleared

RedDress Ltd (Pardes-Hanna, Israel) announced that its RD1 system received United States Food and Drug Administration 510(k) clearance to be marketed in the US. The autologous blood clot product system is intended for use at point-of-care for the safe and rapid preparation of a whole blood clot from a small sample of a patient’s peripheral blood. This product can be topically applied for the management of exuding cutaneous wounds and mechanically or surgically debrided wounds.

For more information, visit www.reddress.co.il. 

Study finds fish skin heals wounds faster than allograft

A recent clinical study found that wounds treated with Omega3 Wound from Kerecis (Arlington, VA) healed significantly faster than wounds treated with a human amniotic membrane allograft. The results were unveiled at the annual American Podiatric Medical Association meeting in July 2018. Each of the patients in the 85-participant study had two 4-mm wounds, one of which was treated with the fish skin product and the other with the allograft. The study found the fish skin product promoted faster wound healing and that more fish skin-treated wounds achieved closure than the allograft-treated wounds.

For more information, visit www.kerecis.com. 

Large wound negative pressure therapy launched

KCI, an Acelity Company (San Antonio, TX), launched the new V.A.C. VERAFLO CLEANSE CHOICE Large Dressing, designed for use with V.A.C. VERAFLO Therapy, to clean larger wounds with thick, fibrous exudate and slough. The dressing also can be used on patients when surgical debridement must be delayed or is not possible or appropriate. Its 3-layer foam design has an array of holes and provides flexibility to treat wounds of various depths, allowing for selective wound cleansing beyond traditional negative pressure therapy dressings.

For more information, visit www.acelity.com. 

Open abdomen dressing now available

KCI, an Acelity Company (San Antonio, TX), launched ABTHERA ADVANCE Open Abdomen Dressing for the United States market. The dressing is a temporary abdominal closure device that uses the technology of the ABTHERA Open Abdomen Negative Pressure Therapy to bridge abdominal wall openings where primary closure is not possible. In addition, it allows for repeat abdominal entries as necessary. This new dressing provides medial tension to minimize fascial retraction and loss of domain while providing separation between the abdominal wall and viscera and protection for the abdominal contents. 

For more information, visit www.acelity.com. 

Ultrasonic debridement shows superior outcomes

Misonix, Inc (Farmingdale, NY), announced the results of a new randomized controlled trial featuring its SonicOne ultrasonic debridement device. In a 70-patient study, the ultrasonic debridement device resulted in better wound appearance, significant reduction in wound area, and superior healing outcomes compared with patients treated with standard sharp debridement.

For more information, visit www.misonix.com. 

New ointments for wound care available 

LAVIOR (Las Vegas, NV) introduced its new D-Care and W-Care ointments to the market for the care and management of chronic wound and inflammatory skin conditions. These ointments use a proprietary extract, AGS BOTANICAL, for an all-in-one wound care solution that addresses biofilm and inflammation. Both ointments work as a Cox-2 inhibitor to reduce cytokine secretion, and they provide auto-debridement by softening eschar and stimulating circulation. These new products offer anti-inflammatory, antibacterial, antifungal, and antiviral properties backed by 8 years of research and development. 

For more information, visit www.lavior.com. 

German wound care company 

Mölnycke Health Care (Gothenburg, Sweden), a global leader in medical solutions, announced its acquisition of wound care products company SastoMed GmbH (Georgsmarienhütte, Germany). The deal adds 2 innovative products to the Swedish company’s portfolio, including Granulox, a hemoglobin-based topical oxygen therapy spray, and Granudacyn, a hypochlorous wound irrigation solution. These new products, in addition to a portfolio that includes a variety of advanced wound care, surgical attire, turning and position, and skin care products, will help lead the way in active and passive wound healing.

For more information, visit www.molnlycke.com. 

New leadership announced for wound care company

Solsys Medical, LLC (Newport News, VA), formerly known as Soluble Systems, LLC, announced Arti Balar Masturzo, MD, as its new Chief Medical Officer. In this new position, Dr. Masturzo will oversee clinical strategy, market access, reimbursement, medical affairs, and medical education. Additionally, she will help guide the company’s strategic direction, including licensing and acquiring new products and supporting the flagship product, TheraSkin, a cryopreserved human skin allograft. Dr. Masturzo most recently held the title of Executive Vice President of Clinical Innovation at Healogics (Jacksonville, FL).

For more information, visit www.solsysmedical.com. 

Regenerative Medicine Company Sponsors Education

Organogensis Inc (Canton, MA) announced sponsorship of 2 educational programs by the American Podiatric Medical Association (APMA). Among the programs are the Residency Education Resource Center, an online educational portal offered free-of-charge to residents and their directors, and the Young Physicians’ Institute, an annual event for residents and new practitioners designed to develop leadership skills in a small group environment.

The company also exhibited at the APMA 2018 Annual Scientific Meeting in Washington, DC. At the meeting, the company’s entire advanced wound care product portfolio was highlighted with product demonstrations and information at their exhibit booth.

For more information, visit www.organogenesis.com. 

Wound management company forges new partnership

Wound Care Advantage (Sierra Madre, CA) announced its newest partnership for full-service management and consulting with Covenant Healthcare (Saginaw, MI). In the deal, the outpatient wound care management company will assist in running the Covenant Wound Healing Center (Saginaw, MI). The center serves 20 counties across central and northeast Michigan with a team of experienced physicians, nurses, clinicians, and technicians for a multidisciplinary, patient-centered approach to wound management.

For more information, visit www.thewca.com. 

Companies partner for DFU study

SANUWAVE Health, Inc (Suwanee, GA) announced a partnership with HyperMed (Memphis, TN) to sponsor a clinical investigation on diabetic foot ulcers (DFUs) starting in August 2018. The multisite case series aims to quantify the level of increased perfusion and oxygenation during and after treatment with the dermaPACE System (SANUWAVE). The device uses pulsed acoustic cellular expression technology to restore the body’s normal healing process.

For more information, visit www.sanuwave.com. 

Partnership will expand infrared imaging device distribution

Perry Baromedical (Riviera Beach, FL) is partnering with Kent Imaging, Inc (Calgary, Alberta, Canada) to distribute the KD203, a near infrared imaging device. Through the partnership, the hyperbaric chamber manufacturer will expand its innovative offerings. The tissue assessment technology is an noninvasive and cost-effective method of assessing the effects of hyperbaric therapy on wound oxygenation and wound health. It reports oxygen saturation, relative oxyhemoglobin, and relative deoxyhemoglobin levels in superficial tissue with a multispectral imaging to determine at-risk tissue and guide treatment protocols.

For more information, visit https://www.prnewswire.com/news-releases/perry-baromedical-and-kent-imag....

Telehealth wound care service recognized

MyWoundDoctor, LLC (Nashville, TN), received the 2nd Place Prize and the AARP Audience Choice Award at the 2018 Northeastern University Nurse Innovation & Entrepreneurship Competition (Boston, MA). The telehealth wound care service provides patients with personalized care at an affordable cost through certified wound care nurse and physician oversight. The service is licensed to provide consultations in over 40 states and provides a case rate fee for telehealth consultation and daily supplies based on expected duration of treatment.

For more information, visit www.mywounddoctor.com.